Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on September 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

BENZONATATE CAPSULES

Closed
SPE2DP-26-T-4957Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-4957 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharma FSA for the procurement of Benzonatate Capsules, USP, 100 MG. The requirement consists of two bottles of 100 capsules each, identified by NSN 6505-00-660-1798. The product is regulated by the FDA and must adhere to a non-extendable shelf-life requirement of 36 months. Delivery is required within 20 days after the order, with FOB and inspection/acceptance points set at the destination. Shipping locations include Fort Drum, New York, and Prince Sultan AB, Saudi Arabia. The capsules must be stored at a controlled room temperature between 20 and 25 degrees Celsius and protected from light, moisture, and humidity. Packaging and marking must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, with specific adherence to hazardous material labeling under 29 CFR 1910.1200. The contract incorporates various FAR and DFARS clauses, including the Buy American Act, safeguarding of covered defense information, and the use of the Wide Area WorkFlow system for electronic invoicing. Quotes must be submitted via the DIBBS system by September 15, 2026.

General Info

DLA seeks quotes for Benzonatate Capsules, NSN 6505-00-660-1798, due September 15, 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

SAU

Set-Aside

NONE

Documents

1

SPE2DP-26-T-4957 Request for Quotations

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Solicitation

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
BENZONATATE CAPSULES
BENZONATATE CAPSULES,USP, 100 MG, 100'S. 100 MILLIGRAMS OF BENZONATATE
ACTIVE INGREDIENT.UNIT OF ISSUE: BOTTLE (BT) OF 100ea. The capsules should be protected from light, moisture and humidity, and stored at controlled room temperature 20° to 25°C (68° to 77°F).
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
AVKARE LLC 4QGW8 P/N NDC42291-0091-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0927-01 PROFICIENT RX LP 7GU24 P/N NDC71205-0885-00
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018213517 0001 BT 2.000
NSN/MATERIAL:6505006601798
SPE2DP-26-T-4957
SECTION B
PR: 7018213517 PRLI: 0001 CONT’D
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-660-1798 Quantity: 2 BT Purchase Request: 7018213517QTY: 2 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS